valeriana officinalis
Botanicalexperimental
Valerian is a perennial flowering plant native to Europe and Asia. It produces a catnip-like response in cats. — Wikipedia
Clinical trial activity
5 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
3
Phase 4
0
Earliest trial started Mar 1, 2003 (NCT01612130)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaValerian (herb) ↗
- NCATSJWF5YAW3QW ↗
Also known as
- valeriana officinalis
- valeriana officinalis extract
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05194618 | Phase 2/Phase 3 (Phase 3) | Feb 2, 2022 | University of Bordeaux |
| NCT04093271 | Phase 1 | Sep 30, 2019 | KGK Science Inc., LifeSeasons Inc. |
| NCT01178632 | Phase 3 | Oct 1, 2010 | Millet Roux |
| NCT00075842 | Phase 3 | Aug 1, 2003 | Mayo Clinic, National Cancer Institute (NCI) |
| NCT01612130 | N/A | Mar 1, 2003 | Federal University of the Valleys of Jequitinhonha and Mucuri, University of Campinas |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Federal University of the Valleys of Jequitinhonha and Mucuri | Academic/Hospital | 1 | 1 | 1 | 2003 |
| KGK Science Inc. | For profit | 1 | 0 | 1 | 2019 |
| LifeSeasons Inc. | For profit | 1 | 1 | 1 | 2019 |
| Mayo Clinic | Academic/Hospital | 1 | 0 | 1 | 2003 |
| Millet Roux | Academic/Hospital | 1 | 1 | 1 | 2010 |
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 2003 |
| University of Bordeaux | Academic/Hospital | 1 | 1 | 1 | 2022 |
| University of Campinas | Academic/Hospital | 1 | 0 | 1 | 2003 |
8 organizations
Page 1 / 1